Newsletter

Torin1 restores proliferation rate in Charcot-Marie-Tooth disease type 2A cells harbouring MFN2 (mitofusin 2) mutation Feb 3, 2023
How T118M peripheral myelin protein 22 predisposes humans to Charcot-Marie-Tooth disease Dec 26, 2022

Combined RNA interference and gene replacement therapy targeting MFN2 as proof of principle for the treatment of Charcot-Marie-Tooth type 2A Nov 25, 2023
Mouse models of human CNTNAP1-associated congenital hypomyelinating neuropathy and genetic restoration of murine neurological deficits Oct 19, 2023
Intravenous Administration of an AAV9 Vector Ubiquitously Expressing C1orf194 Gene Improved CMT-Like Neuropathy in C1orf194-/- Mice Oct 16, 2023
Clinical trials in Charcot-Marie-Tooth disorders: a retrospective and preclinical assessment Sep 22, 2023
Structures of wild-type and selected CMT1X mutant connexin 32 gap junction channels and hemichannels Aug 30, 2023
AAV9-mediated SH3TC2 gene replacement therapy targeted to Schwann cells for the treatment of CMT4C Aug 27, 2023
Proteostasis plays an important role in demyelinating Charcot Marie Tooth disease Aug 19, 2023